Tropical Medicine and Health (Sep 2024)

A serological survey of COVID-19 among predominantly aboriginal residents of a tourist island in southern Thailand

  • Supakorn Sripaew,
  • Kameelah Yasharad,
  • Dzerlina S. Rahari,
  • Weiyan Feng,
  • Zhenzhu Qian,
  • Huynh Ngoc Thanh,
  • Pei Li,
  • Agus Fitriangga,
  • Satiti Palupi Purwanto,
  • Aye Nyein Phyu,
  • Fangming Xianyu,
  • Sombat Phadungvitvatthana,
  • Wit Wichaidit,
  • Ponlagrit Kumwichar,
  • Virasakdi Chongsuvivatwong

DOI
https://doi.org/10.1186/s41182-024-00617-0
Journal volume & issue
Vol. 52, no. 1
pp. 1 – 12

Abstract

Read online

Abstract Background The current survey describes the seroprevalence, history of coronavirus disease 2019 (COVID-19), and vaccination status among predominantly aboriginal residents on a tourist island in southern Thailand. This information can be translated into COVID-19 vaccination and control plans for this population. Methods We implemented questionnaire interviews and collected blood samples from 249 residents of Lipe Island, Satun Province, in January 2022. We measured the anti-nucleocapsid protein and anti-spike (anti-S) receptor-binding protein levels of immunoglobulin (Ig) M and IgG. The differences in antibody levels among participants with different histories of vaccination and infection were analyzed using one-way analysis of variance with multiple comparisons. Results During the 2-year pandemic period, no island residents with COVID-19 required hospitalization despite the high prevalence of hypertension (33.3%) and diabetes mellitus (21.7%). Approximately 18.8% of the participants reported a history of COVID-19 diagnosis. In total, 95.1% of the participants had a history of complete vaccination, of which 93.5% were seropositive. The anti-S IgG geometric means (geometric standard deviation) were 3945.8 (2.0), 829.8 (9.7) AU/mL, 789.9 (5.3) AU/mL, and 22.7 (7.1) AU/mL, respectively, in participants with a history of both COVID-19 diagnosis and complete vaccination (group 1), incomplete vaccination and subsequent COVID-19 diagnosis (group 2), complete vaccination but no previous infection (group 3), or neither previous COVID-19 and complete vaccination (group 4). Significant pairwise differences in anti-S IgG levels were found between certain groups (1 vs 3, 1 vs 4, 2 vs 4, and 3 vs 4). Conclusions The high coverage of vaccination, high levels of population antibody titers, variable antibody levels among completely vaccinated non-infected residents, and high prevalence of non-communicable diseases (NCDs) suggested that the local health systems could control the pandemic. However, continuing surveillance, booster vaccinations, and NCD prevention programs were still required.

Keywords